These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Weight Gain While Switching from Polypharmacy to Ziprasidone: A Case Report. Lee CP; Chen AP; Juang YY Clin Schizophr Relat Psychoses; 2015; 9(3):141-4. PubMed ID: 23644168 [TBL] [Abstract][Full Text] [Related]
4. Weight gain--as possible predictor of metabolic syndrome. Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110 [TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities]. Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734 [TBL] [Abstract][Full Text] [Related]
6. Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis. Pérez-Iglesias R; Ortiz-Garcia de la Foz V; Martínez García O; Amado JA; Garcia-Unzueta MT; Ayesa-Arriola R; Suarez-Pinilla P; Tabares-Seisdedos R; Crespo-Facorro B Schizophr Res; 2014 Oct; 159(1):90-4. PubMed ID: 25151200 [TBL] [Abstract][Full Text] [Related]
7. Ziprasidone induced symptomatic bradycardia: a case report. Menon V; Kattimani S; Ayyanar S Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298 [No Abstract] [Full Text] [Related]
10. A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics. Lu BY; Lundgren R; Escalona PR; Roberts BB J Clin Psychiatry; 2002 Dec; 63(12):1185-6. PubMed ID: 12530423 [No Abstract] [Full Text] [Related]
11. A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder. Das P J Clin Psychopharmacol; 2016 Aug; 36(4):393-4. PubMed ID: 27281388 [No Abstract] [Full Text] [Related]
12. Electrocardiographic changes with ziprasidone. Loebel A; Miceli J; Chappell P; Siu C J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311 [No Abstract] [Full Text] [Related]
13. Antipsychotic-induced weight gain: a comprehensive research synthesis. Allison DB; Mentore JL; Heo M; Chandler LP; Cappelleri JC; Infante MC; Weiden PJ Am J Psychiatry; 1999 Nov; 156(11):1686-96. PubMed ID: 10553730 [TBL] [Abstract][Full Text] [Related]
14. A case of ziprasidone associated with acutely worsened diabetes mellitus. Honigberg MC; Bui MP; Coconcea C Psychosomatics; 2013; 54(3):304-5. PubMed ID: 23680062 [No Abstract] [Full Text] [Related]
15. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment. Brieger P J Clin Psychiatry; 2004 Jan; 65(1):132-5. PubMed ID: 14744182 [No Abstract] [Full Text] [Related]